HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY
|
0.730 |
AlteredExpression
|
disease |
BEFREE |
DARS expression is significantly enriched in the cerebellum, a region affected in HBSL patients and important for motor control.
|
29615866 |
2018 |
HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY
|
0.730 |
Biomarker
|
disease |
BEFREE |
In summary, our data is an important contribution to a better understanding of DARS function and HBSL pathology.
|
27816769 |
2017 |
HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Adolescents with mutations in DARS can present with a comparable clinical picture, broadening the clinical spectrum of hypomyelination with brainstem and spinal cord involvement and leg spasticity.
|
25527264 |
2015 |
HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Adolescents with mutations in DARS can present with a comparable clinical picture, broadening the clinical spectrum of hypomyelination with brainstem and spinal cord involvement and leg spasticity.
|
25527264 |
2015 |
HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Adolescents with mutations in DARS can present with a comparable clinical picture, broadening the clinical spectrum of hypomyelination with brainstem and spinal cord involvement and leg spasticity.
|
25527264 |
2015 |
HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Adolescents with mutations in DARS can present with a comparable clinical picture, broadening the clinical spectrum of hypomyelination with brainstem and spinal cord involvement and leg spasticity.
|
25527264 |
2015 |
HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A practical approach to diagnosing adult onset leukodystrophies.
|
24357685 |
2014 |
HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Here, we report on the application of high-throughput genome and exome sequencing to a cohort of ten individuals with a leukoencephalopathy of unknown etiology and clinically characterized by hypomyelination with brain stem and spinal cord involvement and leg spasticity (HBSL), as well as the identification of compound-heterozygous and homozygous mutations in cytoplasmic aspartyl-tRNA synthetase (DARS).
|
23643384 |
2013 |
HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Here, we report on the application of high-throughput genome and exome sequencing to a cohort of ten individuals with a leukoencephalopathy of unknown etiology and clinically characterized by hypomyelination with brain stem and spinal cord involvement and leg spasticity (HBSL), as well as the identification of compound-heterozygous and homozygous mutations in cytoplasmic aspartyl-tRNA synthetase (DARS).
|
23643384 |
2013 |
HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY
|
0.730 |
GermlineCausalMutation
|
disease |
ORPHANET |
Here, we report on the application of high-throughput genome and exome sequencing to a cohort of ten individuals with a leukoencephalopathy of unknown etiology and clinically characterized by hypomyelination with brain stem and spinal cord involvement and leg spasticity (HBSL), as well as the identification of compound-heterozygous and homozygous mutations in cytoplasmic aspartyl-tRNA synthetase (DARS).
|
23643384 |
2013 |
HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY
|
0.730 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY
|
0.730 |
Biomarker
|
disease |
CTD_human |
|
|
|
HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY
|
0.730 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Lower limb spasticity
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
DARS-associated leukoencephalopathy can mimic a steroid-responsive neuroinflammatory disorder.
|
25527264 |
2015 |
Lower limb spasticity
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
DARS-associated leukoencephalopathy can mimic a steroid-responsive neuroinflammatory disorder.
|
25527264 |
2015 |
Lower limb spasticity
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
DARS-associated leukoencephalopathy can mimic a steroid-responsive neuroinflammatory disorder.
|
25527264 |
2015 |
Leukoencephalopathy
|
0.130 |
Biomarker
|
group |
BEFREE |
DARS-associated leukoencephalopathy can mimic a steroid-responsive neuroinflammatory disorder.
|
25527264 |
2015 |
Leukoencephalopathy
|
0.130 |
GeneticVariation
|
group |
BEFREE |
Here, we investigate six mutants of the aspartyl-tRNA synthetase correlated with leukoencephalopathies.
|
26620921 |
2015 |
Leukoencephalopathy
|
0.130 |
GeneticVariation
|
group |
BEFREE |
Mutations in the nuclear gene coding for the mitochondrial aspartyl-tRNA synthetase, a key enzyme for mitochondrial translation, are correlated with leukoencephalopathy.
|
21121901 |
2011 |
Leukoencephalopathy
|
0.130 |
Biomarker
|
group |
HPO |
|
|
|
Leukodystrophy
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Missense mutations of the gene encoding DARS result in the leukodystrophy hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) with a distinct pattern of hypomyelination, motor abnormalities, and cognitive impairment.
|
29615866 |
2018 |
Leukodystrophy
|
0.120 |
Biomarker
|
disease |
BEFREE |
In vivocharacterization of the aspartyl-tRNA synthetase DARS: Homing in on the leukodystrophy HBSL.
|
27816769 |
2017 |
Leukodystrophy
|
0.120 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Diabetes Mellitus, Non-Insulin-Dependent
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
|
28736931 |
2018 |
White Blood Cell Count procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |